Syndromes of Thrombotic Microangiopathy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28189178.
- Also identified by DOI 10.1016/j.mcna.2016.09.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thrombotic thrombocytopenia purpura (TTP) and the hemolytic uremic syndrome (HUS) are rare thrombotic microangiopathies that can be rapidly fatal. Although the acquired versions of TTP and HUS are generally highest on this broad differential, multiple rarer entities can produce a clinical picture similar to TTP/HUS, including microangiopathic hemolysis, renal failure, and neurologic compromise. More recent analysis has discovered a host of genetic factors that can produce microangiopathic hemolytic syndromes. This article discusses the current understanding of thrombotic microangiopathy and outlines the pathophysiology and causative agents associated with each distinct syndrome as well as the most accepted treatments.
Medical subject headings
- Hemolytic-Uremic Syndrome
- Purpura, Thrombotic Thrombocytopenic
- Thrombotic Microangiopathies